EVT-0002518

N/A

Report date: 2024/08/02 17:44:04
NME

Base Information

Drug NameEVT-0002518
Drug Alias NameEVT-0002518
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase inhibitors
TargetsMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase
Therapy Area/IndicationsLung NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvariste Technologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEvariste Technologies Ltd
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A